GE
Disrupting
Itself
We call the process used to IN MAY 2009, General Elecsold modified Western develop the two machines and tric announced that over the next six years it would spend billion products to emerging take them global reverse innovation, because it’s the opposite of to create at least health-care markets. Now, to the glocalization approach that innovations that would substantially lower costs, increase access, preempt the emerging many industrial-goods manufacturers based in rich countries and improve quality. Two prodgiants, it’s trying have employed for decades. With ucts it highlighted at the time – a glocalization, companies develop , handheld electrocardiothe reverse. great products at home and then gram device and a portable, PCdistribute them worldwide, with some adaptations based ultrasound machine that sells for as little as to local conditions. It allows multinationals to make , – are revolutionary, and not just because the optimal trade-o between the global scale so of their small size and low price. They’re also excrucial to minimizing costs and the local customizatraordinary because they originally were developed tion required to maximize market share. Glocalizafor markets in emerging economies (the ECG detion worked fine in an era when rich countries acvice for rural India and the ultrasound machine for counted for the vast majority of the market and other rural China) and are now being sold in the United countries didn’t o er much opportunity. But those States, where they’re pioneering new uses for such days are over – thanks to the rapid development of machines.
Is
For decades, GE has
by Jeffrey R. Immelt, Vijay Govindarajan, and Chris Trimble
56 Harvard Business Review
|
October 2009
|
hbr.org
Tom Burns
hbr.org
|
October 2009
|
Harvard Business Review 57
How GE Is Disrupting Itself
populous countries like China and India and the slowing growth of wealthy nations. GE badly needs innovations like the low-cost ECG and ultrasound machines, not only to expand beyond high-end segments in places like China and India but also to preempt local companies in those countries – the emerging giants – from creating similar products and then using them to disrupt GE in rich countries. To put it bluntly: If GE’s businesses are to survive and prosper in the next decade, they must become as adept at reverse innovation as they are at glocalization. Success in developing countries is a prerequisite for continued vitality in developed ones. The problem is that there are deep conflicts between glocalization and reverse innovation. And the company can’t simply replace the first with the second, because glocalization will continue to dominate strategy for the foreseeable future. The two models need to do more than coexist; they need to cooperate. This is a heck of a lot easier said than done since the centralized, product-focused structures and practices that have made multinationals so successful at glocalization actually get in the way of reverse innovation, which requires a decentralized, local-market focus. Almost all the people and resources dedicated to reverse innovation e orts must be based and managed in IN BRIEF the local market. These local growth teams need to have » The model that GE and other P&L responsibility; the power industrial manufacturers have to decide which products to followed for decades – developing develop for their markets and high-end products at home and how to make, sell, and service adapting them for other markets them; and the right to draw around the world – won’t suffice as growth slows in rich nations. from the company’s global resources. Once products » To tap opportunities in emerghave proven themselves in ing markets and pioneer value emerging markets, they must segments in wealthy countries, be taken global, which may companies must learn reverse innovation: developing products in involve pioneering radically countries like China and India and new applications, establishing then distributing them globally. lower price points, and even using the innovations to canni» While multinationals need both balize higher-margin products approaches, there are deep conflicts between the two. But those in rich countries. All of those conflicts can be overcome. approaches are antithetical to the glocalization model. This » If GE doesn’t master reverse article aims to share what GE innovation, the emerging giants has learned in trying to overcould destroy the company. come that conflict.
IDEA
Glocalization is so dominant today because it has delivered. Largely because of glocalization, GE’s revenues outside the United States soared from . billion, or % of total revenues, in , to billion, or more than half of the total, in . The model came to prominence when opportunities in today’s emerging markets were pretty limited – when their economies had yet to take o and their middle or low-end customer segments didn’t exist. Therefore, it made sense for multinational manufacturers to simply o er them modifications of products for developed countries. Initially, GE, like other multinationals, was satisfied with the % to % growth rates its businesses enjoyed in developing countries, thanks to glocalization. Then in September one of the coauthors of this piece, Je Immelt, who had just become GE’s CEO, set a goal: to greatly accelerate organic growth at the company and become less dependent on acquisitions. This made people question many things that had been taken for granted, including the glocalization strategy, which limited the company to skimming the top of emerging markets. A rigorous analysis of GE’s health-care, power-generation, and power-distribution businesses showed that if they took full advantage of opportunities that glocalization had ignored in heavily populated places like China and India, they could grow two to three times faster there. But to do that, they’d have to develop innovative new products that met the specific needs and budgets of customers in those markets. That realization, in turn, led GE executives to question two core tenets of glocalization: Assumption 1: Emerging economies will largely evolve in the same way that wealthy economies did. The reality is, developing countries aren’t following the same path and could actually jump ahead of developed countries because of their greater willingness to adopt breakthrough innovations. With far smaller per capita incomes, developing countries are more than happy with high-tech solutions that deliver decent performance at an ultralow cost – a % solution at a % price. And they lack many of the legacy infrastructures of the developed world, which were built when conditions were very di erent. They need communications, energy, and transportation products that address today’s challenges and opportunities, such as unpredictable oil prices and ubiquitous wireless technologies. Finally, because of their huge populations, sustainability problems are especially urgent for countries like China and India. Because of this,
Why Reverse Innovation Is So Important
58 Harvard Business Review
|
October 2009
|
hbr.org
they’re likely to tackle many environmental issues years or even decades before the developed world. All this isn’t theory. It’s already happening. Emerging markets are becoming centers of innovation in fields like low-cost health-care devices, carbon sequestration, solar and wind power, biofuels, distributed power generation, batteries, water desalination, microfinance, electric cars, and even ultra-low-cost homes. Assumption 2: Products that address developing countries’ special needs can’t be sold in developed countries because they’re not good enough to compete there. The reality here is, these products can create brand-new markets in the developed world – by establishing dramatically lower price points or pioneering new applications. Consider GE’s health-care business in the United States. It used to make most of its money on premium computed tomography (CT) and magnetic
Before the financial crisis plunged the world into a deep recession, GE’s leaders had been looking to emerging markets to help achieve their ambitious growth objectives. Now they’re counting on these markets even more because they think that a er the downturn ends, the developed world will su er a prolonged period of slow growth – % to % a year. In contrast, annual growth in emerging markets could easily reach two to three times that rate. Ten years ago when GE senior managers discussed the global marketplace, they talked about “the U.S., Europe, Japan, and the rest of the world.” Now they talk about “resource-rich regions,” such as the Middle East, Brazil, Canada, Australia, and Russia, and “people-rich regions,” such as China and India. The “rest of world” means the U.S., Europe, and Japan. To be honest, the company also is embracing reverse innovation for defensive reasons. If GE
Preempting the Emerging Giants
Reverse innovation isn’t optional; resonance (MR) imaging machines. But to succeed in the era of broader access and reduced reimbursement that President Obama hopes to bring about, the business will probably need to increase by % the number of products it o ers at lower price points. And that doesn’t mean just cheaper versions of high-tech products like imaging machines. The company also must create more o erings like the heated bassinet it developed for India, which has great potential in U.S. inner cities, where infant deaths related to the cold remain high. And let’s not forget that technology o en can be improved until it satisfies more demanding customers. The compact ultrasound, which can now handle imaging applications that previously required a conventional machine, is one example. (See “Reverse Innovation in Practice.”) Another is an aircra engine that GE acquired when it bought a Czech aerospace company for million. GE invested an additional million to further develop the engine’s technology and now plans to use it to challenge Pratt & Whitney’s dominance of the small turboprop market in developed countries. GE’s cost position is probably half of what Pratt’s is.
it’s oxygen.
doesn’t come up with innovations in poor countries and take them global, new competitors from the developing world – like Mindray, Suzlon, Goldwind, and Haier – will. In GE’s markets the Chinese will be bigger players than the Indians will. The Chinese have a real plan to become a major global force in transportation and power generation. GE Power Generation is already regularly running into Chinese enterprises as it competes in Africa, which will be an extremely important region for the company. One day those enterprises may compete with GE in its own backyard. That’s a bracing prospect. GE has tremendous respect for traditional rivals like Siemens, Philips, and Rolls-Royce. But it knows how to compete with them; they will never destroy GE. By introducing products that create a new price-performance paradigm, however, the emerging giants very well could. Reverse innovation isn’t optional; it’s oxygen.
A Clash of Two Models
Glocalization has defined international strategy for three decades. All the currently dominant ideas – from Christopher A. Bartlett and Sumantra
hbr.org
|
October 2009
|
Harvard Business Review 59
How GE Is Disrupting Itself
Ghoshal’s “transnational” strategy to Pankaj Ghemawat’s “adaptation-aggregation” trade-o – fit within the glocalization framework. Since organization follows strategy, it’s hardly surprising that glocalization also has molded the way that multinationals are structured and run. GE is a case in point. For the past years, its organization has evolved to maximize its e ectiveness at glocalization. Power and P&L responsibility were concentrated in global business units headquartered in the developed world. The major business functions – including R&D, manufacturing, and marketing – were centralized at headquarters. While some R&D centers and manufacturing operations were moved abroad to tap overseas talent and reduce costs, they focused mainly on products for wealthy countries. While this approach has enormous advantages, it makes reverse innovation impossible. The experiences of Venkatraman Raja, the head of GE Healthcare’s business in India, illustrate why. GE Healthcare sells an x-ray imaging product called a surgical C-arm, which is used in basic surger-
ies. A high-quality, high-priced product designed for hospitals in wealthy countries, it has proven tough to sell in India. Raja saw the problem and made a proposal in . He wanted to develop, manufacture, and sell a simpler, easier-to-use, and substantially cheaper product in India. His proposal made sense, and yet, to no one’s surprise, it was not approved. If you were a leader of a GE operation in a developing country, as Raja was, here’s what you were up against: Your formal responsibilities included neither general management nor product development. Your responsibility was to sell, distribute, and service GE’s global products locally and provide insights into customers’ needs to help the company adapt its o erings. You were expected to grow revenues by % to % a year and make sure that costs increased at a much slower rate, so that margins rose. You were held rigidly accountable for delivering on plan. Just finding the time for an extracurricular activity like creating a proposal for a product tailored to the local market was challenging. That was nothing, however, compared with the challenge of the next step: selling your proposal in-
Reverse Innovation in Practice
1
ORIGINAL PRODUCT
CONVENTIONAL ULTRASOUND 2002 PRICE
In the 1990s GE served the Chinese ultrasound market with machines developed in the U.S. and Japan.
2
THE EMERGING MARKET DISRUPTION
$100K AND UP
TYPICAL CUSTOMERS Sophisticated hospital imaging centers TYPICAL USES Cardiology (such as measuring the size of passages or blood flow in the heart) Obstetrics (monitoring fetal health) General radiology (assessing prostate health, for example)
But the expensive, bulky devices sold poorly in China.
In 2002 a local team in China leveraged GE’s global resources to develop a cheap, portable machine using a laptop computer enhanced with a probe and sophisticated software.
60 Harvard Business Review
|
October 2009
|
hbr.org
ternally. Doing so required getting the attention of the general manager at headquarters in the United States, who sat two or more levels above your immediate boss and was far more familiar with a worldrenowned medical center in Boston than a rural clinic outside Bangalore. Even if you got the meeting, you’d have limited time to make your case. (India accounted for just % of GE’s revenues at the time and occupied roughly the same mindshare of managers with global responsibility.) If you were extremely persuasive, you might be invited to share the proposal with others. But when you visited the head of global manufacturing, you’d have to counter arguments that a simple, streamlined global product line was much more e cient than custom o erings. When you visited the head of marketing, you’d have to deal with fears that a lower-priced product would weaken the GE brand and cannibalize existing sales. When you met with the head of finance, you’d have to wrestle with concerns that lower-priced products would drag down overall margins. And when you visited the head of global R&D, you’d have to explain why the energies of GE’s scientists and engineers – including those in
technology centers in emerging markets – should be diverted from projects directed at its most sophisticated customers, who paid top dollar. Even if you gained support from each of these executives and got the proposal o the ground, you’d still have to compete for capital year a er year against more certain projects with shorter-term payo s. Meanwhile, of course, you’d still have to worry about making your quarterly numbers for your day job. It was little wonder that successful e orts to develop radically new products for poor countries were extremely rare.
Shifting the Center of Gravity
Obviously, changing long-established structures, practices, and attitudes is an enormous task. As is the case in any major change program, the company’s top leaders have to play a major role. To do so, they must investigate firsthand the size of the opportunity and how it could be exploited and encourage the teams running the corporation’s businesses to do the same. As GE’s CEO, Je goes to China and India two times a year. When he’s in, say, China, he’ll spend a day at GE’s research center in
PORTABLE ULTRASOUND 2002 PRICE
2007 PRICE
$30K–$40K
TYPICAL CUSTOMERS China: rural clinics U.S.: ambulance squads and emergency rooms TYPICAL USES China: spotting enlarged livers and gallbladder stones U.S.: in emergency rooms to identify ectopic pregnancies; at accident sites to check for fluid around the heart; in operating rooms to place catheters for anesthesia
$15K
In 2007 the team launched a dramatically cheaper model. Sales in China took off.
3
2002
THE NEW GLOBAL MARKET
PORTABLE ULTRASOUND 2009 PRICE
PORTABLE ULTRASOUND GLOBAL REVENUES
$4M
2008
$15K–$100K
CONVENTIONAL ULTRASOUND 2009 PRICE
$278M
$100K–$350K
Thanks to technology advances, higher-priced PC-based models can now perform radiology and obstetrics functions that once required a conventional machine.
hbr.org
|
October 2009
|
Harvard Business Review 61
How GE Is Disrupting Itself
Shanghai and then meet separately with dozens of people in the company’s local business operations and just let them talk about what they’re working on, what their cost points are, who their competitors are, and so on. On such visits, he has realized that there’s a whole realm of technology that the company should be applying faster. While in China, Je will also talk with government leaders, including President Hu Jintao. Hu has told Je about his plans to develop China’s economy and how making health care a ordable for all citizens fits into that. It takes a conversation like that to fully appreciate the opportunities in China. In India, Je will have dinner with the CEOs of Indian companies. At one dinner Anand Mahindra talked about how his company, Mahindra & Mahindra, was making life miserable for John Deere in India with a tractor that cost half the price of Deere’s but was still enormously profitable. Such discussions drive home the point that you can make a lot of money in India if you have the right business models. So the job of the CEO – of any senior business leader, for that matter – is to connect all the dots and then act as a catalyst. It’s to give initiatives special status and funding and personally monitor them on a monthly or quarterly basis. And perhaps most important in the case of reverse innovation, it’s to push your enterprise to come up with the new organizational form that will allow product and business-model innovation to flourish in emerging markets.
they delivered lower quality than CT or MR scanners, they did so at much lower cost. The company aimed to be number one in ultrasound. Over the next decade, GE Healthcare expanded its presence in the market. It built an R&D facility for developing new ultrasound products near its headquarters, in Milwaukee, and made acquisitions and entered into joint ventures around the world. It competed in all three of the primary market segments – obstetrics, cardiology, and general radiology – by launching premium products that
To develop that new organizational form, GE did what it has always done: learn from other companies’ experiences but also try to find an internal group that somehow had managed to overcome the hurdles and achieve success. During their annual strategy review, the company’s leaders spotted one in the ultrasound unit of GE Healthcare. GE Healthcare’s primary business is high-end medical-imaging equipment. By the late s it had become clear that a new technology – ultrasound – had a bright future. Ultrasound machines, like the other imaging devices, were typically found in sophisticated imaging centers in hospitals. While
A Homegrown Model
employed cutting-edge technologies. By , GE Healthcare had established solid market positions in rich countries around the world. The results in developing countries, by contrast, were disappointing. By , with the help of a joint venture partner in China, GE saw the problem: In wealthy countries performance mattered most, followed by features; in China price mattered most, followed by portability and ease of use. The priorities weren’t the same because the health-care infrastructure of China was so di erent from that of rich countries. More than % of China’s population relied (and still relies) on poorly funded, low-tech hospitals or basic clinics in rural villages.
62 Harvard Business Review
|
October 2009
|
hbr.org
These facilities had no sophisticated imaging centers, and transportation to urban hospitals was di cult, especially for the sick. Patients couldn’t come to the ultrasound machines; the ultrasound machines, therefore, had to go to the patients. There was no way that GE could meet that need by simply scaling down, removing features from, or otherwise adapting its existing ultrasound machines, which were large, bulky, expensive, and complex. It needed a revolutionary product. In , the company launched its first compact ultrasound, which combined a regular laptop com-
More than of China’s population still relies on poorly funded, low-tech hospitals or basic clinics in rural villages.
90%
puter with sophisticated so ware. It sold for as low as , . In late , GE introduced a model that sold for as low as , , less than % of the cost of GE’s high-end ultrasound machines. Of course, its performance was not as high, but it was nonetheless a hit in rural clinics, where doctors used it for simple applications, such as spotting enlarged livers and gallbladders and stomach irregularities. The so ware-centric design also made it easy to adjust the machine – for example, to improve the interfaces – a er observing how doctors worked with it. Today the portable machine is the growth engine of GE’s ultrasound business in China.
Even more exciting, the innovation has generated dramatic growth in the developed world by pioneering new applications where portability is critical or space is constrained, such as at accident sites, where the compacts are used to diagnose problems like pericardial e usions (fluid around the heart); in emergency rooms, where they are employed to identify conditions such as ectopic pregnancies; and in operating rooms, where they aid anesthesiologists in placing needles and catheters. Six years a er their launch, portable ultrasounds were a million global product line for GE, one that was growing at % to % a year before the worldwide recession hit. Someday every general practitioner may carry both a stethoscope and a compact ultrasound device embedded in his or her PDA. The products owe their successful development to an organizational anomaly in GE: the existence of multiple ultrasound business units. Although the three primary segments of the ultrasound business are vastly di erent, GE’s initial instinct was to follow the glocalization model when it built the business – that is, to create a single integrated global organization. In , however, Omar Ishrak, a newcomer who had been hired to lead the business, saw that meshing operations would reduce them to a common denominator that served nobody well. He decided to run the business as three independent business units with their own P&L responsibility, all reporting to him. When the compact ultrasound e ort began in China, Ishrak saw that the new business would have little in common with the three units, which were focused on premium products. So instead, he created a fourth independent unit, based in Wuxi, China. It evolved the local growth team (LGT) model, which is based on five critical principles. 1. Shift power to where the growth is. Without autonomy, the LGTs will become pawns of the global business and won’t be able to focus on the problems of customers in emerging markets. Specifically, they need the power to develop their own strategies, organizations, and products. Ishrak understood this and gave such broad authority to Diana Tang and J.K. Koo, the leaders of GE’s ultrasound e ort in China. The pair of GE veterans had deep experience in the ultrasound business, expertise in biomedical engineering and general management, and lengthy careers in Asia.
hbr.org
|
October 2009
|
Harvard Business Review 63
How GE Is Disrupting Itself
2. Build new offerings from the ground up. Given the tremendous gulfs between rich countries and poor ones in income, infrastructure, and sustainability needs, reverse innovation must be zerobased. These wide di erences cannot be spanned by adapting global products. The compact ultrasound was built from scratch, although it drew heavily from an existing R&D e ort. In the late s, in a product-development center in Israel, GE had started to experiment with a revolutionary new architecture – one that shi ed most of the muscle inside an ultrasound machine from the hardware to the so ware. Instead of a large box full of custom hardware, the scientists and engineers involved in the project envisioned a standard highperformance PC, special peripherals such as an ultrasound probe, and sophisticated so ware.
reach China’s vast and fragmented rural markets and third-tier cities. And instead of relying on GE Healthcare’s global customer-support and replacementparts organizations, it built in-country teams that could provide quicker and less costly service. 4. Customize objectives, targets, and metrics. Innovation endeavors are, by nature, uncertain. It’s more important to learn quickly by e ciently testing assumptions than to hit the numbers. So the relevant metrics and standards for LGTs – the ones that resolve the critical unknowns – are rarely the same as those used by the established businesses. The ultrasound LGT knew that doctors in rural China were less familiar with ultrasounds than doctors in cities. But the team didn’t know how much experience rural doctors had with the technology or what features would meet their needs. So it set out
In the midst of a severe global recession,
The concept generated little excitement in GE Healthcare at the time because it could not come close to matching the performance of the business’s premium products. But Ishrak quickly saw the value of the new architecture in developing countries. He encouraged the team in China to pursue the concept further. The resulting compact ultrasound based on a laptop computer hit the mark in China. 3. Build LGTs from the ground up, like new companies. Zero-based innovation doesn’t happen without zero-based organizational design. GE’s organizational “so ware” – its hiring practices, reporting structures, titles, job descriptions, norms for working relationships, and power balances between functions – all evolved to support glocalization. LGTs need to rewrite the so ware. Tang and Koo constructed a business unit that managed a complete value chain: product development, sourcing, manufacturing, marketing, sales, and service. By recruiting locally, they were able to find most of the expertise they needed – including engineers with deep knowledge of miniaturization and low-power consumption and a commercialization team well versed in health care in rural China. The LGT also decided that dealers – rather than the direct sales force used by the premium ultrasound units – were the only cost-e ective way to
GE’s businesses in China to learn how doctors reacted to the machines and what the obstacles to their adoption were. The team discovered that ease of use, especially in primarycare screenings, where doctors test for common local conditions, was even more crucial than anticipated. In response, the new business emphasized training, o ered online guides, designed simpler keyboards, created built-in presets for certain tasks, and tracked customer satisfaction to gauge success. Ishrak was careful to use di erent criteria to evaluate the performance of the LGT in China. For example, because the government approval process for new product releases is less intricate in China, he set much shorter product-development cycles than were common in wealthy countries. He also agreed to allow the size of the local service organization to deviate from the GE Healthcare’s global standards. Since salaries are lower and service is more demanding in China, a bigger sta relative to the number of installed machines made sense. 5. Have the LGT report to someone high in the organization. LGTs cannot thrive without strong support from the top. The executive overseeing the LGT has three critical roles: mediating conflicts between the team and the global business, connecting the team to resources such as global R&D centers, and helping take the innovations that the team de-
64 Harvard Business Review
|
October 2009
|
hbr.org
velops into rich countries. Only a senior executive in the global business unit, or even its leader, can accomplish all of that. Even when it was tiny, the LGT in China reported directly to Ishrak. Because GE Healthcare had an ambitious product-development agenda for rich countries when the compact project was launched, the LGT’s engineers might easily have been redirected to other projects if Ishrak hadn’t shielded the team. He protected and even expanded the team’s resources. By its number of engineers had grown from to and its total payroll had increased from to . Ishrak also personally made sure that the team got the expertise it needed from other parts of GE, such as three highly respected development engineers from Israel, Japan, and South Korea. They worked full-time on the project and got it extra support from GE’s R&D centers around the world. Ishrak included the China LGT in the company’s Ultrasound Council, a group of ultrasound executives
will grow 25% this year, largely because of local growth teams. and market and technology experts who meet for two days three times a year. At the meeting they share knowledge and insights and agree on which major projects to pursue. The council was instrumental in moving knowledge and technology into China. Finally, Ishrak played a critical role in building a global market for the portable ultrasound. He identified potential new applications in the developed world and saw to it that the three units that sold the premium products aggressively pursued those opportunities.
•••
China and India have increased their focus on the problems of developing countries, the vast majority of their resources are still devoted to initiatives for developed ones. So there is still a long way to go. It’s still necessary for the company’s top executives to monitor and protect local e orts and make sure they get resources. It’s still necessary to experiment with people transfers, organizational structures, and processes to see what works. The biggest experiment is about to come: To speed progress in India, GE is creating a separate P&L that will include all GE businesses in that country and giving the new unit considerable power to tap GE’s global R&D resources. It will be headed by a senior vice president who will report to a vice chairman. That’s anathema in a company used to a matrix in which product comes first and country second. Nonetheless, the company is going to try it and see if it can create new markets. GE has to learn how to operate on a di erent axis. The resistance to giving India its own P&L reflects what is perhaps GE’s biggest challenge: changing the mind-set of managers who’ve spent their careers excelling at glocalization. Even the exemplars have a richcountry bias. In a recent conversation with Jeff, one such manager – the head of a major business that’s doing well in India and China – still seemed preoccupied with problems beyond his control in the U.S. “I don’t even want to talk to you about your growth plans for the U.S.,” Je responded. “You’ve got to triple the size of your Indian business in the next three years. You’ve got to put more resources, more people, and more products in there, so you’re deep in that market and not just skimming the very top. Let’s figure out how to do it.” That’s how senior managers have to think.
Jeffrey R. Immelt is chairman and chief executive o cer of General Electric. Vijay Govindarajan (vg@
GE now has more than a dozen local growth teams in China and India. In the midst of a severe global recession, GE’s businesses in China will grow % this year – largely because of LGTs. It’s way too early to declare victory, however. Progress has been uneven. While some businesses – notably, health care and power generation and distribution – have taken the ball and run with it, others have been less enthusiastic. And though GE’s R&D centers in
dartmouth.edu) is the Earl C. Daum Professor of International Business and director of the Center for Global Leadership at the Tuck School of Business at Dartmouth and is professor in residence and chief innovation consultant at GE. Chris Trimble (chris. trimble@dartmouth.edu) is on the faculty of Tuck and consults to GE.
Reprint R0910D To order, see page 143.
hbr.org
|
October 2009
|
Harvard Business Review 65
You May Also Find These Documents Helpful
-
GE better known as General Electric, history dates back to 1870, but now is one of the numbers on corporation.GE also is the multinational in the country. GE starts back with locomotive engine and has work its way up to more useful thing we use every day in our everyday life. General Electric is a positive Co. who knows how to capitalize on the growth themes of the era. They believe in speed, and lowering cost. Because of the performance, they are the world most competitive company. They feel investing in infrastructure helps to competes and create jobs.GE won in the growth market, they know to do global and local. Others countries wants the same as GE, they want capabilities, and competitive to bring about jobs, pride, and progress to lift peoples spirits.…
- 1091 Words
- 4 Pages
Good Essays -
General Electric is a multinational corporation that is divided into six distinct divisions. These include GE Technology Infrastructure, GE Healthcare, GE Energy Infrastructure, NBC Universal, GE Capital Finance, and GE Consumer and Industrial. They are the twelfth-largest company in the world by revenue and the second-largest company by market capitalization. The diversity and size of General Electric gives them a lot of protection against the poor performance of one industry. It also allows them to sell and obtain new corporations at opportune moments.…
- 3579 Words
- 15 Pages
Powerful Essays -
Therefore, it must be utilized properly and have a production reputation. Technologies such as imaging devices for invasive or intensive cardiology procedures and non-invasive oncology platforms should be carefully considered to provide doctors and patients with options for treating certain medical conditions. This might require to spend more money, however, installing upgraded technologies in the hospital, it will benefit the hospital by receiving more patients to treat for their medical condition instead of sending them to a different hospital with upgraded technology and the hospital will also make more money as well, which they can use towards other necessary tools that are…
- 682 Words
- 3 Pages
Good Essays -
The emerging giants tap abudant low-cost labor, tech talent, and mineral resources to increasingly target the world’biggest growth market.…
- 489 Words
- 2 Pages
Satisfactory Essays -
Key Factors Global Expansion Medical Device Innovation Acquisitions Aging Population Government Regulations Operation and Production Costs TWI…
- 4440 Words
- 18 Pages
Best Essays -
Capital investments and risk associated with international market entry were also concerning for company like Genicon and choosing a right market was crucial as due to lack of financial resources and personnel, Genicon was facing an opportunity cost as well. Multinational companies often have capital and infrastructure along with international expertise and resources which were requirement for international market entry and success. There was also a challenge of dealing with regulatory bodies at several international companies and contracts were done on bidding basis and socialized medicine concept also was a risk factor for profit even though if Genicon were able to obtain contract. Though laparoscopic device industry was growing but healthcare market had favored GPO and large companies were able to afford bigger discounts and GENICON had inability to sell any significant amount of products in US market. Also due…
- 1103 Words
- 5 Pages
Powerful Essays -
The control of development and generalization of medical technology is fragmented. Identify control points, and suggest ways to improve them. Distinguish the private and public sectors.…
- 778 Words
- 4 Pages
Good Essays -
For years GEMS has been exploiting the global product structure which enabled the company to increase its value around the globe. However, this structure has also created challenges within organization and its strategy. With Global product company philosophy, General Electric Medical Systems had made separate joint ventures for CT, X- Ray and ultrasound partnering with regulatory government such as Ministry of Health and the State Drug Administration and their subsidiary manufacturing groups. Due to this, GEMS encountered some challenges associated with these partnerships. Mr. Chen describes that “In one joint venture, partner firm would receive orders for equipment, and then service the orders from its separately and wholly owned factory, thus cutting us out” (GEMS 2002, pg. 14). In addition, according to D. E. Westney and S. Zaheer, the Global product structure has a potential weakness. The structure lacks responsiveness to local needs and local customer needs whose demands don’t fit profile expected by the business unit. Also, it is unable to leverage potential synergies across product lines within a country. (D. E. Westney and S. Zaheer, pg. 732) I agree, Strategic issues in one particular country cannot be systematically solved in a different country. In order to implement the business model, the company should create specific strategy which complies with a local market demand and local government regulations. Keith Morgan shows that Chinese government demand GEMS attention. He states, “Some years ago, brokers purchased used medical equipment for the West and dumped it in China. The Chinese government deemed this insulting and banned the sale of used equipment. Without such equipment, rural hospitals would be denied of functionality.” (GEMS 2002, pg. 15) In addition, in order to analyze a new market, a company should integrate local skills and expertise within the mainframe of the business structure. In…
- 580 Words
- 3 Pages
Good Essays -
Narayana emerged initially as the world’s largest focused‐factory, lowest‐cost, and high quality cardiac care facility, initiated in Bangalore. It then subsequently morphed into a large Health City, and then spread geographically across India, and via diagnosis‐by‐telemedicine all over the world. Now, it has opened a state‐of‐the‐art facility in the Cayman Islands, to serve the Caribbean, and within striking distance of large numbers of US under‐insured, but just outside US regulatory waters.…
- 737 Words
- 4 Pages
Satisfactory Essays -
Let’s look in detail how this new medical technology gets adopted in the US. It may come in the form of:…
- 842 Words
- 4 Pages
Good Essays -
Innovations such as magnetic resonance imaging (MRI), new highly effective drugs, improvements in surgical procedures such as organ transplantation, coronary artery bypass surgery, just to name a few, have completely transform our modern way of life and the standards of health care. The research and development of medical technology have given us enormous outcomes and benefits. It is a source of hope for the prevention, effective treatment, and cure of diseases. Unfortunately, just like any new product, the cost of developing these new technologies and treatments is extremely high. Plus, unlike other technology, medical technology generally does not decrease in price over time (Fuchs & Garber:…
- 1590 Words
- 7 Pages
Better Essays -
More specifically, it has changed the way doctors’ tackle the life threatening cardiovascular disease. The use of technology and methods for treating this disease has evolved to its current status, with dramatically lower mortality rates then before. It also questioned how technological change in medicine has affected and varied in different countries around the world. Researchers have done cross-national comparisons. This paper also had to come to the conclusion that the differences trace to economic and regulatory incentives (“Technological Change”, n. d.). Another question was what affects technological changes. By comparing data from credible sources worldwide, researchers also came to the conclusions that technological changes are affected by national health policies as medical spending has increased everywhere. Incentives that differ in every country also affect the rate and quality of technological change. For example, there is a strong correlation with higher reimbursement and effective treatment. It has said that “supply- side” incentives are important for technological changes (McClellan and Kessler, 1999). This research has led to a key discovery that humans are incredibly intelligent to have come so far in such a short amount of time. Also, came to the conclusion that all the great revolutionary inventors of those technologies all had the deep desire to change the face of medicine and ultimately the health of humans everywhere. Each wanted to make the treatment of patients better. The only real difference is that they came from many different parts of the world. The only gap or thing left to answer is the issue regarding the appropriate and efficient use of the technology being used by medical personnel. From here on out, researchers are continuing to do more researching, learning, and growing to keep improving. Through more…
- 2035 Words
- 9 Pages
Better Essays -
The legacy of Medtronic Corporation, the company that created the cardiac pacemaker industry, is a proud one. Starting from its earliest pacemakers, which had to be carried outside the body, Medtronic had achieved dramatic improvements in the functionality, size and reliability of these devices. In so doing it had extended the lives, and improved the quality of life, for hundreds of thousands of people in whom pacemakers had been implanted. The pacemaker has been designated as one of the ten most outstanding engineering achievements in the world over the past 50 years, along with the digital computer and the Apollo 11 moon landing. 1 Medtronic, which in 1995 booked operating profit of $300 million on revenues of $1.7 billion, had been founded in 1957 in Minneapolis, Minnesota by Earl Bakken, a researcher and inventor who had to his credit patents on several of the crucial technologies that led to the modern heart pacemaker. Pacemakers were small, battery-powered devices which, when implanted within a patient, helped a malfunctioning heart to beat in a steady, fixed rhythm. Because Medtronic was the first entrant into the pacemaker field and built a strong technological lead, it enjoyed a substantial portion (over 70%) of the market share for cardiac pacing through the 1960s. Building upon Medtronic’s legacy of leadership was not easy, however. In the face of increasing competition, rapid technological change and tightening market and regulatory demands for product quality, Medtronic saw its market share cut by more than half between 1970 and 1986. Though it had invested heavily in technology and product development over this period, much of that investment had been unproductive. Many projects failed to produce product designs that could be launched competitively, and the features and functionality of most of the products the company was able…
- 8613 Words
- 35 Pages
Good Essays -
Working on a new, innovative and an easy to use product in the form of Pulse in the growing market of medical technology, New World Computing has tapped what is a very promising business idea. With limited competition and superior product design, the firm has immense potential to mass market its product and to reap the benefits of the growing medical information system industry.…
- 3651 Words
- 15 Pages
Powerful Essays